Support teaching, research, and patient care.
My research and clinical work focuses on medical and surgical innovation, including the development and testing of novel surgical and clinical devices and methods. I am a Faculty Fellow in the Stanford Biodesign Innovation Program, and I work with and advise early stage startups in the medical and mobile health spaces.
Surgical correction of fistulas and other pelvic floor disorders
My research is focused on the development and testing of novel minimally invasive treatment modalities for complex pelvic floor disorders.
Adaptive Design Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair for Persistent or Recurrent Stress Urinary Incontinence Following Surgical Treatment
This study evaluates the efficacy and safety of Autologous Muscle Derived Cells for Urinary
Sphincter Repair (AMDC-USR; generic name: iltamiocel) compared to a placebo in the reduction
of stress incontinence episode frequency in adult female patients with post-surgical
persistent or recurrent stress urinary incontinence (SUI). Half of the participants will
receive AMDC-USR (injections with cells) and the other half will receive placebo.
View full details
ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study
The primary objective of this study is to assess the safety and effectiveness of MatriStem
Pelvic Floor Matrix as compared to native tissue repair for the treatment of pelvic organ
prolapse. Patients are evaluated throughout a 3 year follow-up period.
Bulking Agents for the Treatment of Stress Urinary Incontinence in Females
The primary purpose of this study is to demonstrate the safety and effectiveness of Bulkamid®
in the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency
(ISD) in adult women who have SUI or stress predominant mixed incontinence
Study of the Elevate Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse
The aim of this study is to further evaluate the safety and efficacy of the Elevate® Apical
and Posterior Prolapse Repair System for repair of apical/posterior pelvic organ prolapse in
a controlled, post-market cohort study.
Efficacy Study of Vaginal Mesh for Anterior Prolapse
The primary aim of this double-blind, randomized clinical trial (RCT) is to test the
hypothesis that the addition of a standardized technique of interpositional synthetic
polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery
for anterior prolapse compared to traditional vaginal reconstructive surgery without mesh.
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
This is a multi-centered, randomized prospective single blinded clinical trial comparing CO2
fractionated vaginal laser therapy and vaginal estrogen cream therapy in the treatment of
Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence
The aim of this postmarket study is to compare the safety and effectiveness of the Altis
Single Incision Sling (SIS) to an FDA cleared transobturator and/or retropubic sling through
Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse
The aim of this study is to further evaluate the safety and efficacy of the Elevate® Anterior
and Apical Prolapse Repair System for repair of anterior/apical pelvic organ prolapse in a
controlled, post-market cohort study.
Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy
The purpose of this study is to assess the safety and the efficacy of a laser in the
treatment of vulvovaginal atrophy (VVA), that is to assess the change in the severity of the
vaginal dryness symptom, by means of a visual analogic scale (10 cm VAS).
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
This randomized, double-blind, placebo-controlled, multicenter, confirmatory study will
evaluate the efficacy and safety of Cook MyoSite Incorporated Autologous Muscle-Derived Cells
(generic name Iltamiocel) compared to a placebo (vehicle) control dose in the treatment of
stress urinary incontinence (SUI) in adult female patients.
Restorelle® Mesh Versus Native Tissue Repair for Prolapse
The purpose of this study is to collect information on the safety and effectiveness of
Restorelle Direct Fix mesh and the surgical procedure to implant Restorelle. These results
will be compared to the safety and effectiveness results in patients who have native tissue
repair (without mesh) as their pelvic organ prolapse treatment.